Clinical Trial Update: Atazanavir for HIV Infected Individuals: An Early Access Program

View source ↗

Summary

This report states that the Atazanavir Early Access Program for HIV-infected individuals has ended and is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• ATAZANAVIR (atazanavir)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: HIV Infections | Status: NO_LONGER_AVAILABLE